Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Thromb Res. 2014 May 14;134(2):449–454. doi: 10.1016/j.thromres.2014.05.003

Table 1.

Correlation of full-length and thrombin-cleaved OPN with laboratory and coagulation markers.

Laboratory findings/Coagulation markers Critical Phase Recovery Phase
FL-OPN (IBL) trOPN FL-OPN (IBL) trOPN
r P r P r P r P
Increase of Hct (%) 0.37 <0.01 - n.s. - n.s. - n.s.
Plt (103/ul) −0.44 <0.001 - n.s. - n.s. −0.32 <0.05
Ly (%) - n.s. - n.s. −0.29 <0.05 0.28 <0.05
Mono (%) - n.s. −0.26 <0.05 - n.s. - n.s.
Viral RNA (copy/ml) - n.s. 0.46 <0.001
TAT (ng/ml) - n.s. −0.37 <0.01 0.42 <0.001 −0.34 <0.01
D-dimer (ng/ml) 0.26 <0.05 - n.s. 0.42 <0.001 - n.s.
TM (pg/ml) - n.s. - n.s. - n.s. - n.s.
Ferritin (ng/ml) 0.25 <0.05 - n.s. - n.s. 0.33 <0.01

Abbreviation: TAT, thrombin anti-thrombin complex; TM, thrombomodulin; OPN, osteopontin; FL, full-length; tr, thrombin-cleaved.